Skip to main content
Equibles

FRANKLIN RESOURCES INC

Position in ENTA — Enanta Pharmaceuticals Inc

CIK 38777 San Mateo, CA
Back to ENTA Full portfolio

Position in ENTA

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$707,390
-$138,149 QoQ
Shares Held
48,518
-27.5% QoQ
Ownership
0.167%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#43
of 122 holders
Holding Since
Dec 2021
10 quarters on record
Voting authority Sole 99% Shared 0% None 1%

Common Shares in ENTA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

FRANKLIN RESOURCES INC holds $9,184,405,765 across 177 Biotechnology names. ENTA ranks #153 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 REGN
Regeneron Pharmaceuticals, Inc.
 2,771,839 $1,728,352,485
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,347,253 $1,662,680,977
3 ASND
Ascendis Pharma A/S
 1,862,503 $496,766,798
4 JAZZ
Jazz Pharmaceuticals plc
 2,040,250 $491,639,040
5 RVMD
Revolution Medicines, Inc.
 1,488,394 $278,746,426
6 INSM
INSMED Inc
 2,273,222 $242,370,927
7 LGND
Ligand Pharmaceuticals Inc
 752,044 $237,713,585
8 ARGX
Argenx SE
 224,930 $208,683,303

All Filings in ENTA

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $707,390 48,518
2026-03-31 $845,539 66,947
2025-12-31 $515,992 32,720
2024-09-30 $265,142 25,593
2024-06-30 $339,540 26,179
2024-03-31 $507,491 29,066
2023-03-31 $201,955 4,994
2022-12-31 $233,761 5,025
2022-09-30 $310,025 5,977
2021-12-31 $206,466 2,761